Arthronica

Arthronica raised over 1.2 million pounds in a 2020 pre-seed round. Investors in the round included AI Seed, Crista Galli Ventures, Entrepreneur First, RebelBio and SOSV.

Arthronica was a London-based medical research startupstart-up that focused on chronic arthritis. The company was spunoutspun out from the bioengineering department at the Imperial College London in 2018. Arthronica was headed by founder and CEO Letizia Gionfrida, a researcher and participant in the MedTech SuperConnector accelerator. The company entered liquidation in September 2021, and was acquired by Procedure Health Limited in March 2022.

Arthronica raised over 1.2 million pounds in a 2020 pre-seed round. Investors in the round included AI Seed, Crista Galli Ventures, Entrepreneur First, RebelBio and SOSV.

Arthronica was a London-based medical research startup that focused on chronic arthritisarthritis. The company was spunout from the bioengineering department at the Imperial College LondonImperial College London in 2018. Arthronica was headed by founder and CEO Letizia GionfridaLetizia Gionfrida, a researcher and participant in the MedTech SuperConnector accelerator. The company entered liquidation in September 2021, and was acquired by PrcoedureProcedure Health Limited Health Limited in March 2022.

Arthronica was a software-as-a-service (SaaS) platform to remotely diagnose arthritis. The platform relied on patients' smartphone or laptop cameras as well as artificial intelligence software. Arthronica was designed to provide rapid data access to both patients and doctors in order to optimize recovery.

Arthronica is a digital platform that leverages computer vision to monitor and diagnose chronic arthritis.

Arthronica was a London-based medical research startup that focused on chronic arthritis. The company was spunout from the bioengineering department at the Imperial College London in 2018. Arthronica was headed by founder and CEO Letizia Gionfrida, a researcher and participant in the MedTech SuperConnector accelerator. The company entered liquidation in September 2021, and was acquired by Prcoedure Health Limited in March 2022.